The gut microbiota in IBD
暂无分享,去创建一个
Francisco Guarner | Natalia Borruel | Chaysavanh Manichanh | C. Manichanh | N. Borruel | F. Casellas | F. Guarner | Francesc Casellas
[1] S. Pender. Do metalloproteinases contribute to tissue destruction or remodeling in the inflamed gut? , 2008, Inflammatory bowel diseases.
[2] R. Knight,et al. Bacterial Community Variation in Human Body Habitats Across Space and Time , 2009, Science.
[3] James R. Cole,et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis , 2008, Nucleic Acids Res..
[4] S. Mazmanian,et al. The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.
[5] N. Borruel,et al. Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission , 2008, The American Journal of Gastroenterology.
[6] N. Pace,et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.
[7] N. Borruel,et al. Increased mucosal tumour necrosis factor α production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria , 2002, Gut.
[8] C. Filippo. Impact of diet in shaping gut microbiota , 2012 .
[9] N. Borruel,et al. Effects of Nonpathogenic Bacteria on Cytokine Secretion by Human Intestinal Mucosa , 2003, American Journal of Gastroenterology.
[10] E. K. Kemsley,et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota , 2010, BMC gastroenterology.
[11] C. Manichanh,et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.
[12] Subrata Ghosh,et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.
[13] Tarah Lynch,et al. Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host , 2011, Inflammatory bowel diseases.
[14] T. Ohkusa,et al. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis , 2003, Gut.
[15] J. Doré,et al. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray , 2010, Inflammatory bowel diseases.
[16] Eoin L. Brodie,et al. Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.
[17] P. Brandtzaeg. Mucosal Immunity: Induction, Dissemination, and Effector Functions , 2009, Scandinavian journal of immunology.
[18] V. Mai,et al. Monitoring of Stool Microbiota in Subjects with Diarrhea Indicates Distortions in Composition , 2006, Journal of Clinical Microbiology.
[19] N. Nielsen,et al. Cesarean section and offspring's risk of inflammatory bowel disease: A national cohort study , 2012, Inflammatory bowel diseases.
[20] R Balfour Sartor,et al. Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.
[21] C. Bernstein,et al. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases , 2008, Gut.
[22] S. Mazmanian,et al. A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.
[23] N. Borruel,et al. Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa , 2009, Inflammatory bowel diseases.
[24] B. Chassaing,et al. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. , 2011, Gastroenterology.
[25] L. Proctor,et al. The Human Microbiome Project in 2011 and beyond. , 2011, Cell host & microbe.
[26] Miguel Pignatelli,et al. Metatranscriptomic Approach to Analyze the Functional Human Gut Microbiota , 2011, PloS one.
[27] Henrik Svanström,et al. Antibiotic use and inflammatory bowel diseases in childhood , 2010, Gut.
[28] J. Cummings,et al. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis , 2000, Gut.
[29] N. Borruel,et al. Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease , 2006, Journal of leukocyte biology.
[30] P. Mannon,et al. The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.
[31] G. Oppenheimer,et al. REGIONAL ILEITIS: A PATHOLOGIC AND CLINICAL ENTITY , 1932 .
[32] J. Coffey,et al. Desulfovibrio Bacterial Species Are Increased in Ulcerative Colitis , 2010, Diseases of the colon and rectum.
[33] M. Pop,et al. Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.
[34] I. Forgacs,et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. , 1996, Gut.
[35] J. Doré,et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.
[36] J. Hampe,et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.
[37] Ateequr Rehman,et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. , 2011, Gastroenterology.
[38] P. Brigidi,et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria , 2004, Gut.
[39] E. Purdom,et al. Diversity of the Human Intestinal Microbial Flora , 2005, Science.
[40] T. Ohkusa,et al. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species‐specific antibody , 2002, Journal of gastroenterology and hepatology.
[41] C R Woese,et al. Classification of methanogenic bacteria by 16S ribosomal RNA characterization. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[42] J. Jansson,et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease , 2008, The ISME Journal.
[43] C. Manichanh,et al. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis , 2013, Alimentary pharmacology & therapeutics.
[44] F. Guarner,et al. Mechanisms of Disease: the hygiene hypothesis revisited , 2006, Nature Clinical Practice Gastroenterology &Hepatology.
[45] J. Blanco,et al. Molecular diversity of Escherichia coli in the human gut: New ecological evidence supporting the role of adherent‐invasive E. coli (AIEC) in Crohn's disease , 2009, Inflammatory bowel diseases.
[46] Matthew W. Johnson,et al. The Bacteriology of Pouchitis: A Molecular Phylogenetic Analysis Using 16S rRNA Gene Cloning and Sequencing , 2010, Annals of surgery.
[47] N. Pace,et al. Gastrointestinal microbiology enters the metagenomics era , 2008, Current opinion in gastroenterology.
[48] P. Bork,et al. A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.
[49] H. Schiöth,et al. Adhesion GPCRs are widely expressed throughout the subsections of the gastrointestinal tract , 2012, BMC Gastroenterology.
[50] G. Rook. Review series on helminths, immune modulation and the hygiene hypothesis: The broader implications of the hygiene hypothesis , 2009, Immunology.
[51] Laurent Beaugerie,et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.
[52] Anders F. Andersson,et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.
[53] W. Babidge,et al. Colonic Sulfide in Pathogenesis and Treatment of Ulcerative Colitis , 1997, Digestive Diseases and Sciences.
[54] S. Pettersson,et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA , 2004, Nature Immunology.
[55] F. Bushman,et al. Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes , 2011, Science.
[56] W. Selby,et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. , 2007, Gastroenterology.
[57] P. Rutgeerts,et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. , 1998, Gastroenterology.
[58] J. Doré,et al. Biodiversity of the Mucosa‐Associated Microbiota Is Stable Along the Distal Digestive Tract in Healthy Individuals and Patients With Ibd , 2005, Inflammatory bowel diseases.
[59] B. Haas,et al. A Catalog of Reference Genomes from the Human Microbiome , 2010, Science.
[60] Fiona Powrie,et al. An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer , 2010, The Journal of experimental medicine.
[61] J. Doré,et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.
[62] J. Doré,et al. Temperature Gradient Gel Electrophoresis of Fecal 16S rRNA Reveals Active Escherichia coli in the Microbiota of Patients with Ulcerative Colitis , 2006, Journal of Clinical Microbiology.
[63] R. Knight,et al. Moving pictures of the human microbiome , 2011, Genome Biology.
[64] Peer Bork,et al. Enterotypes of the human gut microbiome , 2011, Nature.
[65] K. Honda,et al. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.
[66] B. Fleischer,et al. Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease , 1991, The Lancet.
[67] J. Barrett,et al. New IBD genetics: common pathways with other diseases , 2011, Gut.
[68] F. Shanahan,et al. Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.
[69] Sallie W. Chisholm,et al. Whole Genome Amplification and De novo Assembly of Single Bacterial Cells , 2009, PloS one.
[70] C. Manichanh,et al. Colonization by Faecalibacterium Prausnitzii and Maintenance of Clinical Remission in Patients With Ulcerative Colitis , 2011 .
[71] J. Hugot,et al. Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. , 2011, The Journal of clinical investigation.
[72] Manfred Dietel,et al. Mucosal flora in inflammatory bowel disease. , 2002, Gastroenterology.
[73] J. Handelsman,et al. Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. , 1998, Chemistry & biology.
[74] F. Guarner. What is the role of the enteric commensal flora in IBD? , 2008, Inflammatory bowel diseases.
[75] M. Levings,et al. TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic? , 2012, Front. Immun..
[76] N. Borruel,et al. Antiinflammatory Effects of Enterically Coated Amoxicillin‐Clavulanic Acid in Active Ulcerative Colitis , 1998, Inflammatory bowel diseases.
[77] B. Shen,et al. Acute and chronic pouchitis—pathogenesis, diagnosis and treatment , 2012, Nature Reviews Gastroenterology &Hepatology.
[78] W. Ludwig,et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB , 2007, Nucleic acids research.